Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

PROSHARES TRUST (ZBIO) Free Cash Flow: 2023-2024

Historic Free Cash Flow for Zenas BioPharma (ZBIO) over the last 2 years, with Dec 2024 value amounting to -$119.8 million.

  • Zenas BioPharma's Free Cash Flow fell 32.41% to -$41.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$158.6 million, marking a year-over-year decrease of 64.19%. This contributed to the annual value of -$119.8 million for FY2024, which is 292.21% down from last year.
  • Zenas BioPharma's Free Cash Flow amounted to -$119.8 million in FY2024, which was down 292.21% from -$30.5 million recorded in FY2023.
  • In the past 5 years, Zenas BioPharma's Free Cash Flow registered a high of -$30.5 million during FY2023, and its lowest value of -$119.8 million during FY2024.
  • In the last 2 years, Zenas BioPharma's Free Cash Flow had a median value of -$75.2 million in 2023 and averaged -$75.2 million.
  • Data for Zenas BioPharma's Free Cash Flow shows a maximum YoY plummeted of 292.21% (in 2024) over the last 5 years.
  • Over the past 2 years, Zenas BioPharma's Free Cash Flow (Yearly) stood at -$30.5 million in 2023, then slumped by 292.21% to -$119.8 million in 2024.